Disc Medicine to Present Phase 2 Hematology Data at SOHO 2026
Question
Disc Medicine to Present Phase 2 Hematology Data at SOHO 2026
Direct answer
Clinical proof-of-concept readouts for DISC-3405 and DISC-0974 at SOHO directly calibrate the probability of success and addressable market valuation for IRON's hematology pipeline. — bullish pressure on IRON via clinical pipeline trial efficacy readout derisking.
- Original publisher
- Market Ontology
- Evidence through
- 2026-09-01
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Disc Medicine to Present Phase 2 Hematology Data at SOHO 2026”, revision 1, evidence through 2026-09-01. https://marketontology.com/catalysts/2026-09-01/disc-medicine-to-present-phase-2-hematology-data-at-soho-2026-92ef1b
| Asset | Direction | Timeframe | Channel | Score |
|---|---|---|---|---|
| IRON | ▲Bull | 1–5 days | clinical pipeline trial efficacy readout derisking | 53 |
Disc Medicine to Present Phase 2 Hematology Data at SOHO 2026
Clinical proof-of-concept readouts for DISC-3405 and DISC-0974 at SOHO directly calibrate the probability of success and addressable market valuation for IRON's hematology pipeline. — bullish pressure on IRON via clinical pipeline trial efficacy readout derisking.
Disc Medicine presenting Phase 2 data for DISC-3405 and DISC-0974 at SOHO 2026
- SourceDisc Medicine presenting Phase 2 data for DISC-3405 and DISC-0974 at SOHO 2026
- TransmissionClinical proof-of-concept readouts for DISC-3405 and DISC-0974 at SOHO directly calibrate the probability of success and addressable market valuation for IRON's hematology pipeline.
- SummaryDisc Medicine will present multiple Phase 2 clinical datasets at the SOHO 2026 Annual Meeting. The disclosures include RESTORE-PV trial data for DISC-3405 and RALLY-MF data for DISC-0974. The conference presentations serve as major clinical catalysts for hematologic disease indications.
- IRONDirect directional exposure
Illustrative, not advice
- Crowded positioning may already reflect the move
- Counter-catalyst could neutralize the thesis before window closes
- IRON closes below pre-catalyst level on rising volume
- Catalyst narrative is officially walked back or contradicted
- Cross-asset confirmation (rates / FX / vol) reverses direction
- IRON price vs. pre-event level
- IRON volume vs. 20-day average
What happened next
Price follow-up pending — no stored daily closes for these assets yet.
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
Sources
- Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting · press_release · 2026-08-31
Related catalysts
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.